Scipher Medicine Corporation
Scipher Medicine Corporation, a pioneering entity in the biotechnology sector, is headquartered in the United States. Founded in 2017, the company has rapidly established itself as a leader in precision medicine, focusing on the development of innovative solutions for autoimmune diseases. Scipher Medicine's unique approach combines advanced genomic technologies with artificial intelligence to deliver personalised treatment options, setting it apart in a competitive landscape. With a strong emphasis on improving patient outcomes, Scipher's core offerings include its flagship product, Prism, which utilises proprietary algorithms to identify the most effective therapies for individual patients. The company has achieved significant milestones, including strategic partnerships and recognition within the industry for its contributions to personalised healthcare. As it continues to expand its operational reach, Scipher Medicine remains committed to transforming the treatment landscape for autoimmune conditions.
DitchCarbon Score
How does Scipher Medicine Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Scipher Medicine Corporation's score of 3 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Scipher Medicine Corporation's reported carbon emissions
Scipher Medicine Corporation, headquartered in the US, currently does not have publicly available data regarding its carbon emissions or specific climate commitments. There are no reported figures for emissions in any scope (Scope 1, 2, or 3), nor are there documented reduction targets or initiatives. This absence of data suggests that the company may still be in the early stages of developing its climate strategy or reporting framework. As the industry increasingly prioritises sustainability, it will be essential for Scipher Medicine to establish clear climate commitments and measurable targets to align with global efforts in reducing greenhouse gas emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Scipher Medicine Corporation is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
